First Header Logo Second Header Logo

Connection

Roy Hantgan to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Roy Hantgan has written about Drug Administration Schedule.
Roy Hantgan
Connection Strength
0.029
Drug Administration Schedule
  1. Handt S, Jerome WG, Tietze L, Hantgan RR. Plasminogen activator inhibitor-1 secretion of endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: evidence for a key role of endothelial cells in thrombolytic resistance. Blood. 1996 May 15; 87(10):4204-13.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.